Livzon Pharmac Grp Stock Last Dividend Paid
| LP6 Stock | EUR 3.16 0.06 1.94% |
LIVZON PHARMAC GRP fundamentals help investors to digest information that contributes to LIVZON PHARMAC's financial success or failures. It also enables traders to predict the movement of LIVZON Stock. The fundamental analysis module provides a way to measure LIVZON PHARMAC's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to LIVZON PHARMAC stock.
LIVZON |
LIVZON PHARMAC GRP Company Last Dividend Paid Analysis
LIVZON PHARMAC's Last Dividend Paid refers to dividend per share(DPS) paid to the shareholder the last time dividends were issued by a company. In its conventional sense, dividends refer to the distribution of some of a company's net earnings or capital gains decided by the board of directors.
More About Last Dividend Paid | All Equity Analysis
Last Dividend | = | Last Profit Distribution AmountTotal Shares |
Current LIVZON PHARMAC Last Dividend Paid | 1.3 |
Most of LIVZON PHARMAC's fundamental indicators, such as Last Dividend Paid, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, LIVZON PHARMAC GRP is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Many stable companies today pay out dividends to their shareholders in the form of the income distribution, but high-growth firms rarely offer dividends because all of their earnings are reinvested back to the business.
| Competition |
Based on the recorded statements, LIVZON PHARMAC GRP has a Last Dividend Paid of 1.3. This is much higher than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers-Specialty & Generic industry. The last dividend paid for all Germany stocks is notably lower than that of the firm.
Did you try this?
Run Odds Of Bankruptcy Now
Odds Of BankruptcyGet analysis of equity chance of financial distress in the next 2 years |
| All Next | Launch Module |
LIVZON Fundamentals
| Return On Equity | 0.13 | |||
| Return On Asset | 0.0514 | |||
| Profit Margin | 0.15 % | |||
| Operating Margin | 0.15 % | |||
| Shares Outstanding | 309.83 M | |||
| Shares Owned By Insiders | 52.73 % | |||
| Shares Owned By Institutions | 14.83 % | |||
| Price To Earning | 4.02 X | |||
| Revenue | 12.18 B | |||
| Gross Profit | 7.75 B | |||
| EBITDA | 2.3 B | |||
| Net Income | 684.16 M | |||
| Cash And Equivalents | 1.14 B | |||
| Cash Per Share | 1.58 X | |||
| Total Debt | 22.97 M | |||
| Debt To Equity | 1.30 % | |||
| Current Ratio | 2.60 X | |||
| Book Value Per Share | 14.37 X | |||
| Cash Flow From Operations | 192.47 M | |||
| Earnings Per Share | 0.27 X | |||
| Number Of Employees | 8.58 K | |||
| Beta | 0.51 | |||
| Market Capitalization | 3.86 B | |||
| Annual Yield | 0.06 % | |||
| Last Dividend Paid | 1.3 |
About LIVZON PHARMAC Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze LIVZON PHARMAC GRP's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of LIVZON PHARMAC using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of LIVZON PHARMAC GRP based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in LIVZON Stock
LIVZON PHARMAC financial ratios help investors to determine whether LIVZON Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in LIVZON with respect to the benefits of owning LIVZON PHARMAC security.